COVID-19 in China: From epidemiology to treatment (Review)

Hongtao Chen1,2, Shipin Wu1, Xiaoyong Zhang3

  • 1Department of Infectious Diseases, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong 518020, P.R. China.

Insights

This review covers Coronavirus disease 2019 (COVID-19), a novel infectious disease caused by SARS-CoV-2. It details the prevalence, etiology, pathology, clinical signs, diagnosis, and treatment of COVID-19 in China.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Virology

Background:

  • Coronavirus disease 2019 (COVID-19) emerged in Wuhan, China, in December 2019.
  • Caused by the novel SARS-CoV-2, it rapidly spread globally.
  • Initial symptoms included pneumonia, fever, cough, and fatigue.

Purpose of the Study:

  • To review the prevalence of COVID-19 in China.
  • To outline the etiology, pathology, and clinical presentation of the disease.
  • To discuss diagnostic methods and treatment strategies for COVID-19.

Main Methods:

  • Literature review of COVID-19 cases and research.
  • Analysis of epidemiological data from China.
  • Synthesis of information on clinical characteristics and diagnostic findings.

Main Results:

  • As of March 9, 2020, China reported 80,924 confirmed cases and 3,140 deaths.
  • The review details the infectious nature and rapid transmission of SARS-CoV-2.
  • Key clinical features, laboratory findings, and imaging results are presented.

Conclusions:

  • COVID-19 represents a significant global health challenge.
  • Understanding the disease's characteristics is crucial for effective management.
  • This review provides a comprehensive overview of early findings on COVID-19 in China.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...